Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Role of prostanoids in gastrointestinal cancer
Dingzhi Wang, Raymond N. DuBois
Dingzhi Wang, Raymond N. DuBois
Published May 7, 2018
Citation Information: J Clin Invest. 2018;128(7):2732-2742. https://doi.org/10.1172/JCI97953.
View: Text | PDF
Review Series

Role of prostanoids in gastrointestinal cancer

  • Text
  • PDF
Abstract

Chronic inflammation is a risk factor for gastrointestinal cancer and other diseases. Most studies have focused on cytokines and chemokines as mediators connecting chronic inflammation to cancer, whereas the involvement of lipid mediators, including prostanoids, has not been extensively investigated. Prostanoids are among the earliest signaling molecules released in response to inflammation. Multiple lines of evidence suggest that prostanoids are involved in gastrointestinal cancer. In this Review, we discuss how prostanoids impact gastrointestinal cancer development. In particular, we highlight recent advances in our understanding of how prostaglandin E2 induces the immunosuppressive microenvironment in gastrointestinal cancers.

Authors

Dingzhi Wang, Raymond N. DuBois

×

Figure 3

A model of PGE2-regulated tumor-associated immunosuppression.

Options: View larger image (or click on image) Download as PowerPoint
A model of PGE2-regulated tumor-associated immunosuppression.
PGE2 regul...
PGE2 regulates immunosuppressive cells and their functions by (a) inducing MDSC differentiation and production of PD-L1 and arginase I; (b) shifting macrophages from M1 to M2, inducing PD-L1 expression, and reducing macrophage phagocytosis; and (c) inducing differentiation and migration of Tregs. PGE2 regulates DCs and their functions through inhibition of differentiation and maturation; induction of T cell tolerance and IL-23 expression; and induction of dedifferentiation of DCs to MDSCs. PGE2 regulates Th cells and their functions by inducing differentiation and recruitment of Th17, and shifting Th cells from Th1 to Th2. PGE2 regulates CD8+ T cells and their functions by induction of proliferation and tumor antigen–specific tolerance and reduction of CD8+ T cell cytotoxicity. PGE2 regulates NKs and their functions via suppression of cell activation and proliferation and induction of cell apoptosis.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts